TIMP2 and acute kidney injury: These results seem to be supported by a meta-analysis performed by Liu et al., which placed TIMP2*IGFBP7 as an effective AKI predictive biomarker in the ICU and patients who underwent cardiothoracic procedures such as coronary artery bypass graft or transcatheter aortic valve implantation [104].